Hyperfine, Inc.
HYPR • NASDAQ
Hyperfine, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Maria Degois-Sainz, with a market cap of $108.7M.
CEOMaria Degois-Sainz
Next Earnings
Upcoming earnings announcement for Hyperfine, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.09
Revenue Estimate
$3.5M
Earnings History
Past 12 earnings reports for Hyperfine, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Q4 2025 | -$0.06Est: -$0.08 | +25.0% | $5.3MEst: $5.3M | -0.1% | — |
| Nov 13, 2025 | Q3 2025 | -$0.14Est: -$0.10 | -40.0% | $3.4MEst: $3.5M | -2.4% |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.12Est: -$0.12 | 0.0% | $2.7MEst: $3.0M | -8.9% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.12Est: -$0.12 | 0.0% | $2.1MEst: $2.8M | -24.0% | 10-Q |
| Mar 17, 2025 | Q4 2024 | -$0.14Est: -$0.14 | 0.0% | $2.3MEst: $3.0M | -22.6% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.14Est: -$0.14 | 0.0% | $3.6MEst: $3.3M | +10.4% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.14Est: -$0.14 | 0.0% | $3.6MEst: $3.3M | +11.4% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.14Est: -$0.15 | +6.7% | $3.3MEst: $3.1M | +8.0% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.15Est: -$0.18 | +16.7% | $2.7MEst: $3.7M | -27.6% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.15Est: -$0.16 | +6.3% | $2.3MEst: $3.0M | -21.0% | — |
| Aug 14, 2023 | Q2 2023 | -$0.15Est: -$0.16 | +6.3% | $3.4MEst: $2.8M | +20.8% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.17Est: -$0.13 | -30.8% | $2.6MEst: $2.1M | +25.5% | 10-Q |